Surgery Partners (SGRY) insider equity option sale: 25,000 shares, $513K

Rhea-AI Filing Summary

Surgery Partners, Inc. (SGRY) Rule 144 notice shows an insider intends to sell 25,000 newly acquired common shares through UBS Financial Services on 10/08/2025 with an aggregated market value of $513,185.65 based on 128,209,410 shares outstanding. The shares were acquired the same day as an equity option exercise from the company.

The filing also lists multiple recent sales by Wayne DeVeydt totaling numerous transactions between 08/21/2025 and 09/29/2025, including blocks of 100,000, 150,000, and other quantities with individual gross proceeds shown. The filer certifies no undisclosed material adverse information is known at signing.

Positive

• Securities were acquired via an equity option exercise, indicating legitimate compensation rather than external purchase
• Proposed sale amount (25,000 shares, $513,185.65) is small relative to the 128,209,410 shares outstanding

Negative

• Multiple recent large sales by Wayne DeVeydt between 08/21/2025 and 09/29/2025 may indicate continued insider monetization
• Concentrated blocks (100,000; 150,000 shares) in prior transactions generated sizeable gross proceeds and could have added short-term supply

Insights

Corporate Insider / Equity Compensation Analyst

TL;DR: Insider exercised options and plans a 25,000-share sale; several sizeable recent disposals by the same person are disclosed.

The filing reports an equity option exercise and an immediate proposed sale of 25,000 common shares via UBS Financial Services on 10/08/2025

Recent sales by Wayne DeVeydt from 08/21/2025 to 09/29/2025 include multiple large blocks (e.g., 100,000, 150,000) with gross proceeds listed; this indicates ongoing monetization of holdings and creates potential short-term supply into the market. Watch for additional Form 4/Form 144 filings in the near term to confirm ongoing selling pace.

Market Impact / Trading Desk Analyst

TL;DR: The single 25,000-share sale is modest versus outstanding float, but cumulative recent sales are larger and could be locally marketable.

The announced $513,185.65 market value for 25,000 shares is small relative to 128,209,410 shares outstanding, implying limited company-level dilution or impact from this specific block. However, the historical sales listed include much larger blocks whose cumulative gross proceeds sum materially higher and could affect short-term liquidity or trading flows.

Monitor daily volume around 10/08/2025 and any follow-up sales filings to gauge whether selling pressure persists within the coming days.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
common	UBS Financial Services Inc 1000 Harbor Blvd 3rd Floor Weehawken NJ 07086	25000	513185.65	128209410	10/08/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
common	10/08/2025	equity compensation	Surgery Partners, Inc.			25000	10/08/2025	equity option exercise

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Wayne DeVeydt 9910 Cumberland Drive Fishers IN 46037	common	08/21/2025	100000	2299011
Wayne DeVeydt 9910 Cumberland Drive Fishers IN 46037	common	08/26/2025	25000	572717
Wayne DeVeydt 9910 Cumberland Drive Fishers IN 46037	common	08/27/2025	11865	271756
Wayne DeVeydt 9910 Cumberland Drive Fishers IN 46037	common	09/02/2025	25000	562150
Wayne DeVeydt 9910 Cumberland Drive Fishers IN 46037	common	09/03/2025	25000	560251
Wayne DeVeydt 9910 Cumberland Drive Fishers IN 46037	common	09/04/2025	25000	562756
Wayne DeVeydt 9910 Cumberland Drive Fishers IN 46037	common	09/05/2025	25000	563682
Wayne DeVeydt 9910 Cumberland Drive Fishers IN 46037	common	09/08/2025	2014	45207
Wayne DeVeydt 9910 Cumberland Drive Fishers IN 46037	common	09/11/2025	100000	2200741
Wayne DeVeydt 9910 Cumberland Drive Fishers IN 46037	common	09/12/2025	28700	628929
Wayne DeVeydt 9910 Cumberland Drive Fishers IN 46037	common	09/16/2025	25000	541518
Wayne DeVeydt 9910 Cumberland Drive Fishers IN 46037	common	09/17/2025	85785	1873875
Wayne DeVeydt 9910 Cumberland Drive Fishers IN 46037	common	09/18/2025	150000	3294425
Wayne DeVeydt 9910 Cumberland Drive Fishers IN 46037	common	09/19/2025	10613	234547
Wayne DeVeydt 9910 Cumberland Drive Fishers IN 46037	common	09/22/2025	50000	1092666
Wayne DeVeydt 9910 Cumberland Drive Fishers IN 46037	common	09/23/2025	25000	550386
Wayne DeVeydt 9910 Cumberland Drive Fishers IN 46037	common	09/26/2025	5627	123794
Wayne DeVeydt 9910 Cumberland Drive Fishers IN 46037	common	09/29/2025	18134	399822

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the Form 144 for Surgery Partners (SGRY) report?

It reports a proposed sale of 25,000 common shares via UBS Financial Services on 10/08/2025 with an aggregate market value of $513,185.65.

How were the 25,000 shares acquired according to the filing?

The filing states the shares were acquired on 10/08/2025 through equity compensation via an equity option exercise from Surgery Partners, Inc.

Who has been selling Surgery Partners stock recently?

The filing lists multiple sales by Wayne DeVeydt from 08/21/2025 to 09/29/2025, including transactions of 100,000 and 150,000 shares.

Does the filing indicate any undisclosed material information?

By signing the notice, the person represents they have no known material adverse information about the issuer that has not been publicly disclosed.

Where will the proposed sale be executed?

The proposed sale is to be executed on NASDAQ through UBS Financial Services Inc.